Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments. (Q48622786)
Jump to navigation
Jump to search
scientific article published in July 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments. |
scientific article published in July 2013 |
Statements
1 reference
Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments. (English)
1 reference
Alon Kedem
1 reference
Ariel Hourvitz
1 reference
Yuval Yung
1 reference
Libby Shalev
1 reference
Gil M Yerushalmi
1 reference
Hannah Kanety
1 reference
Mirit Hanochi
1 reference
Ettie Maman
1 reference
1 July 2013
1 reference
1 reference
29
1 reference
7
1 reference
651-656
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference